A. Rendon (Monterrey, Mexico), K. Chichirelo-Konstantynovych (Vinnitsya, Ukraine)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Efficacy and safety of chemotherapy regimens containing fluoroquinolones in pediatric TB
Y. Khokhlova (Moscow, Russian Federation), M. Gubkina (Moscow, Russian Federation), N. Yukhimenko (Moscow, Russian Federation), I. Petrakova (Moscow, Russian Federation), S. Sterlikova (Moscow, Russian Federation)
|   |
Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis
A. Burusie (Asella, Ethiopia), F. Enquesilassie (Addis Ababa, Ethiopia), A. Addissie (Addis Ababa, Ethiopia)
| |
Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria
N. Eze (AbujaAAbakalikiA, Nigeria)
| |
Prevalence of the epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions
I. Mokrousov (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), S. Zhdanova (Irkutsk, Russian Federation), T. Umpeleva (Yekaterinburg, Russian Federation), M. Badleeva (Ulan-Ude, Russian Federation), I. Yarusova (Omsk, Russian Federation), A. Gerasimova (St. Petersburg, Russian Federation), R. Mudarisova (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation), N. Eremeeva (Yekaterinburg, Russian Federation), D. Vakhrusheva (Yekaterinburg, Russian Federation), O. Pasechnik (Omsk, Russian Federation), O. Ogarkov (Irkutsk, Russian Federation), V. Zhuravlev (St. Petersburg, Russian Federation), T. Umpeleva (Ekaterinburg, Russian Federation)
| |
The social and structural determinants of tuberculosis incidence trends in 116 countries from 2005-2015: an ecological study
F. Koeltringer (Stockholm, Sweden), K. Annerstedt (Stockholm, Sweden), D. Carter (London, United Kingdom), D. Boccia (London, United Kingdom), W. Rudgard (Oxford, United Kingdom)
| |
Prevalence of Eosinophilia in Patients with Tuberculosis
V. Naidu (london, United Kingdom), M. Belton (london, United Kingdom)
| |
Prevalence of Multidrug Resistant Tuberculosis among TB Patients in Malaysia.
M. Rajendran (Kuala Lumpur, Malaysia)
| |
Effect of air pollution and greenness on the nasal microbiota in infancy
A. Gisler (Basel, Switzerland), I. Korton (Bern, Switzerland), M. Hilty (Bern, Switzerland), K. De Hoogh (Basel, Switzerland), D. Vienneau (Basel, Switzerland), U. Frey (Basel, Switzerland), F. Decrue (Basel, Switzerland), O. Gorlanova (Basel, Switzerland), A. Soti (Bern, Switzerland), P. Latzin (Bern, Switzerland), J. Usemann (Basel, Switzerland)
| |
The combined effect of air pollution and temperature on respiratory health outcomes: a systematic review.
A. Areal (Düsseldorf, Germany), Q. Zhao (Düsseldorf, Germany), C. Wigmann (Düsseldorf, Germany), T. Schikowski (Düsseldorf, Germany)
| |
The effects of national lockdown on incidence of acute exacerbation of chronic obstructive pulmonary disease
R. Cooper (Stoke on Trent, United Kingdom), I. Hussain (Stoke on Trent, United Kingdom), N. Mustfa (Stoke on Trent, United Kingdom), H. Stone (Stoke on Trent, United Kingdom)
| |
Data driven phenotyping and COVID-19 case definitions: a pattern recognition approach
G. Vavougios (Larissa, Greece), C. Konstantatos (Larissa, Greece), P. Sinigalias (Larissa, Greece), S. Zarogiannis (Larissa, Greece), K. Kolomvatsos (Larissa, Greece), K. Gourgoulianis (Larissa, Greece)
| |
Association between antacid proton pump inhibitors and histamine 2 receptor antagonists) and incidence of lung cancer: a population-based cohort analysis
W. Choi (Goyang-si, Republic of Korea), J. Jeong (Daegu, Republic of Korea), C. Lee (Andong, Republic of Korea)
| |
Coronavirus infection (Covid – 19) in children with cystic fibrosis in the Russian Federation
E. Zhekaite (Moscow, Russian Federation), E. Kondratyeva (Moscow, Russian Federation), V. Sherman (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation), Y. Gorinova (Moscow, Russian Federation), A. Voronkova (Moscow, Russian Federation)
| |
Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study
D. Agarwal (Pune, India), N. Hanafi (Kuala Lumpur, Malaysia), E. Khoo (Kuala Lumpur, Malaysia), R. Parker (Edinburgh, United Kingdom), D. Ghorpade (Pune, India), S. Salvi (Pune, India), O. Yusuf (Islamabad, Pakistan), M. Khan (Islamabad, Pakistan), S. Yusuf (Islamabad, Pakistan), D. Das (Vellore, India), B. Paul (Vellore, India), R. Isaac (Vellore, India), M. Islam (Dhaka, Bangladesh), S. Saha (Dhaka, Bangladesh), S. Liew (Kuala Lumpur, Malaysia), N. Hussein (Kuala Lumpur, Malaysia), A. Bakar (Kuala Lumpur, Malaysia), Y. Pang (Kuala Lumpur, Malaysia), K. Chinna (Kuala Lumpur, Malaysia), L. Wong (Kuala Lumpur, Malaysia), S. Juvekar (Pune, India), H. Pinnock (Edinburgh, United Kingdom)
| |
Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.
S. Basin (NANCY, France), S. Valentin (NANCY, France), A. Maurac (NANCY, France), M. Poussel (NANCY, France), B. Pequignot (NANCY, France), A. Brindel (NANCY, France), C. Robert (METZ, France), C. Baumann (NANCY, France), A. Luc (NANCY, France), J. Soler (NANCY, France), F. Chabot (NANCY, France), A. Chaouat (NANCY, France)
| |
COVID-19 Related Deaths in Istanbul
N. Aykac (Istanbul, Turkey), O. Hamzaoglu (Istanbul, Turkey)
| |
Survival and decanulation frequency in out-of-hospital intensive care
A. Bayarassou (Cologne, Germany), S. Herkenrath (Solingen, Germany), W. Rehorn (Düsseldorf, Germany), M. Treml (Solingen, Germany), W. Randerath (Solingen, Germany)
| |
Factors associated with community-acquired pneumonia in-hospital mortality in Portugal
E. Pessoa (Lisbon, Portugal), C. Bárbara (Lisbon, Portugal), A. Costa (Lisbon, Portugal), P. Nogueira (Lisbon, Portugal)
| |
Targeted sequencing of 130 asthma candidate genes and association testing of rare variants with age of onset in Norwegian asthma patients.
G. Nordang (Skien, Norway), Ø. Busk (Skien, Norway), G. Klepaker (Skien, Norway), C. Page (Oslo, Norway), M. Leblanc (Oslo, Norway), Ø. Holla (Skien, Norway), A. Fell (Skien, Norway)
| |